Several fungal diseases have become serious threats to human health and life, especially upon the advent of human immunodeficiency virus/AIDS epidemics and of other typical immunosuppressive conditions of modern life. Accordingly, the burden posed by these diseases and, concurrently, by intensive therapeutic regimens against these diseases has increased worldwide. Existing and available rapid tests for point-of-care diagnosis of important fungal diseases could enable the limitations of current laboratory methods for detection and identification of medically important fungi to be surpassed, both in low-income countries and for first-line diagnosis (screening) in richer countries. As with conventional diagnostic methods and devices, former immunodiagnostics have been challenged by molecular biology-based platforms, as a way to enhance the sensitivity and shorten the assay time, thus enabling early and more accurate diagnosis. Most of these tests have been developed in-house, without adequate validation and standardization. Another challenge has been the DNA extraction step, which is especially critical when dealing with fungi. In this paper, we have identified three major research trends in this field: (1) the application of newer biorecognition techniques, often applied in analytical chemistry; (2) the development of new materials with improved physico-chemical properties; and (3) novel bioanalytical platforms, allowing fully automated testing. Keeping up to date with the fast technological advances registered in this field, primarily at the proof-of-concept level, is essential for wise assessment of those that are likely to be more cost effective and, as already observed for bacterial and viral pathogens, may provide leverage to the current tepid developmental status of novel and improved diagnostics for medical mycology.
AlexanderB. D., PfallerM. A.2006; Contemporary tools for the diagnosis and management of invasive mycosis. Clin Infect Dis 43:Suppl. 1S15–S27 [View Article]
AlgarW. R., MasseyM., KrullU. J.2009; The application of quantum dots, gold nanoparticles and molecular switches to optical nucleic-acid diagnostics. Trends Analyt Chem 28:292–306 [View Article]
ArchibaldL. K., McDonaldL. C., AddisonR. M., McKnightC., ByrneT., DobbieH., NwanyanwuO., KazembeP., RellerL. B., JarvisW. R.2000; Comparison of BACTEC MYCO/F LYTIC and WAMPOLE ISOLATOR 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country. J Clin Microbiol 38:2994–2997[PubMed]
BalajeeS. A., BormanA. M., BrandtM. E., CanoJ., Cuenca-EstrellaM., DannaouiE., GuarroJ., HaaseG., KibblerC. C. et al.2009; Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here?. J Clin Microbiol 47:877–884 [View Article][PubMed]
ChandrasekarP.2010; Diagnostic challenges and recent advances in the early management of invasive fungal infections. Eur J Haematol 84:281–290 [View Article][PubMed]
ChoiS., GoryllM., SinL. Y. M., WongP. K., ChaeJ.2011; Microfluidic-based biosensors toward point-of-care detection of nucleic acids and proteins. Microfluidics Nanofluidics 10:231–247 [View Article]
De CarolisE., PosteraroB., Lass-FlörlC., VellaA., FlorioA. R., TorelliR., GirmeniaC., ColozzaC., TortoranoA. M. et al.2012; Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 18:475–484 [View Article][PubMed]
de HeerK., van der ScheeM. P., ZwindermanK., van den BerkI. A. H., VisserC. E., van OersR., SterkP. J.2013; Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study. J Clin Microbiol 51:1490–1495 [View Article][PubMed]
ForrestG. N., MankesK., Jabra-RizkM. A., WeekesE., JohnsonJ. K., LincalisD. P., VeneziaR. A.2006; Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 44:3381–3383 [View Article][PubMed]
FortinaP., WangJ., SurreyS., ParkJ. Y., KrickaL. J.2007; Beyond microtechnology – nanotechnology in molecular diagnosis. In Integrated Biochips for DNA Analysis, pp. 187–197 Edited by LiuR. H., LeeA. P. New York, NY: Landes Bioscience and Springer Science+Business Media; [View Article]
HsiaoC. R., HuangL., BoucharaJ. P., BartonR., LiH. C., ChangT. C.2005; Identification of medically important molds by an oligonucleotide array. J Clin Microbiol 43:3760–3768 [View Article][PubMed]
IwenP. C., HinrichsS. H., RuppM. E.2002; Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol 40:87–109 [View Article][PubMed]
LacroixC., GicquelA., SendidB., MeyerJ., AccoceberryI., FrançoisN., MorioF., DesoubeauxG., ChandenierJ. et al.2014; Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species. Clin Microbiol Infect 20:153–158 [View Article][PubMed]
LindsleyM. D., MekhaN., BaggettH. C., SurinthongY., AutthateinchaiR., SawatwongP., HarrisJ. R., ParkB. J., ChillerT. et al.2011; Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 53:321–325 [View Article][PubMed]
MaertensJ., VerhaegenJ., LagrouK., Van EldereJ., BoogaertsM.2001; Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97:1604–1610 [View Article][PubMed]
MartinsJ. F. S., CastilhoM. L., CardosoM. A. G., CarreiroA. P., MartinA. A., RanieroL.2012; Identification of Paracoccidioides brasiliensis by gold nanoprobes. Proc SPIE 8219:82190Z [View Article]
McNeilM. M., NashS. L., HajjehR. A., PhelanM. A., ConnL. A., PlikaytisB. D., WarnockD. W.2001; Trends in mortality due to invasive mycotic diseases in the United States, 1980–1997. Clin Infect Dis 33:641–647 [View Article][PubMed]
McTaggartL. R., LeiE., RichardsonS. E., HoangL., FothergillA., ZhangS. X.2011; Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 49:3050–3053 [View Article][PubMed]
Mennink-KerstenM. A. S. H., DonnellyJ. P., VerweijP. E.2004; Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4:349–357 [View Article][PubMed]
NajaG., HrapovicS., MaleK., BouvretteP., LuongJ. H.2008; Rapid detection of microorganisms with nanoparticles and electron microscopy. Microsc Res Tech 71:742–748 [View Article][PubMed]
NeelyL. A., AudehM., PhungN. A., MinM., SuchockiA., PlourdeD., BlancoM., DemasV., SkewisL. R. et al.2013; T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 5:182ra54 [View Article][PubMed]
OdabasiZ., MattiuzziG., EsteyE., KantarjianH., SaekiF., RidgeR. J., KetchumP. A., FinkelmanM. A., RexJ. H., Ostrosky-ZeichnerL.2004; Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39:199–205 [View Article][PubMed]
ParkB. J., WannemuehlerK. A., MarstonB. J., GovenderN., PappasP. G., ChillerT. M.2009; Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525–530 [View Article][PubMed]
PeelingR. W., HolmesK. K., MabeyD., RonaldA.2006; Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect 82:Suppl. 5v1–v6 [View Article][PubMed]
RickertsV., KhotP. D., MyersonD., KoD. L., LambrechtE., FredricksD. N.2011; Comparison of quantitative real time PCR with sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens. BMC Infect Dis 11:202 [View Article][PubMed]
RigbyS., ProcopG. W., HaaseG., WilsonD., HallG., KurtzmanC., OliveiraK., Von OyS., Hyldig-NielsenJ. J. et al.2002; Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin Microbiol 40:2182–2186 [View Article][PubMed]
SchellW. A., BentonJ. L., SmithP. B., PooreM., RouseJ. L., BolesD. J., JohnsonM. D., AlexanderB. D., PamulaV. K. et al.2012; Evaluation of a digital microfluidic real-time PCR platform to detect DNA of Candida albicans in blood. Eur J Clin Microbiol Infect Dis 31:2237–2245 [View Article][PubMed]
SchochC. L., SeifertK. A., HuhndorfS., RobertV., SpougeJ. L., LevesqueC. A., ChenW., BolchacovaE., VoigtK. et al.2012; Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc Natl Acad Sci U S A 109:6241–6246 [View Article][PubMed]
SpanuT., PosteraroB., FioriB., D’InzeoT., CampoliS., RuggeriA., TumbarelloM., CanuG., TrecarichiE. M. et al.2012; Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol 50:176–179 [View Article][PubMed]
TelesF.2013; Biosensors for medical mycology. In Biosensors and their Application in Healthcare pp. 88–111 Edited by Ozkan-AriksoysalD. London: Future Science;
TelesF. R. R., MartinsM. L.2011; Laboratorial diagnosis of paracoccidioidomycosis and new insights for the future of fungal diagnosis. Talanta 85:2254–2264 [View Article][PubMed]
ThorntonC. R.2008; Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 15:1095–1105 [View Article][PubMed]
WheatL. J., GarringerT., BrizendineE., ConnollyP.2002; Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn Microbiol Infect Dis 43:29–37 [View Article][PubMed]
YeoS. F., WongB.2002; Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 15:465–484 [View Article][PubMed]
YooS. M., KangT., KangH., LeeH., KangM., LeeS. Y., KimB.2011; Combining a nanowire SERRS sensor and a target recycling reaction for ultrasensitive and multiplex identification of pathogenic fungi. Small 7:3371–3376 [View Article][PubMed]